InMed Pharmaceuticals Inc. (inm) Misses Q2 EPS by 364c

InMed Pharmaceuticals Inc. (NASDAQ: inm) reported Q2 EPS of ($3.64). Revenue for the quarter came in at $1.11 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (inm) click here.

You May Also Be Interested In

• PG&E Corp, Edison spike on chatter
• S&P shares jump report of potential CapIQ spinout
• Action Behavior Centers' Family Advocacy Team Meets with Congressional Leaders in Washington, D.C., to Discuss Access to ABA Therapy for Autism